{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:56:42Z","timestamp":1790791002171,"version":"4.1.0"},"reference-count":177,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,5]],"date-time":"2021-12-05T00:00:00Z","timestamp":1638662400000},"content-version":"am","delay-in-days":279,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["NSF 1842396"],"award-info":[{"award-number":["NSF 1842396"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL134899"],"award-info":[{"award-number":["R01HL134899"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Applied Materials Today"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.apmt.2020.100887","type":"journal-article","created":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T23:06:35Z","timestamp":1607123195000},"page":"100887","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"special_numbering":"C","title":["Nitric oxide and viral infection: Recent developments in antiviral therapies and platforms"],"prefix":"10.1016","volume":"22","author":[{"given":"Mark R.","family":"Garren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Ashcraft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Douglass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J.","family":"Brisbois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitesh","family":"Handa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apmt.2020.100887_bib0001","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1001\/jama.2020.3413","article-title":"Priorities for the US health community responding to COVID-19","volume":"323","author":"Adalja","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.apmt.2020.100887_bib0002","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.antiviral.2014.07.014","article-title":"Nitazoxanide: a first-in-class broad-spectrum antiviral agent","volume":"110","author":"Rossignol","year":"2014","journal-title":"Antivir Res"},{"key":"10.1016\/j.apmt.2020.100887_bib0003","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet North Am Ed"},{"key":"10.1016\/j.apmt.2020.100887_bib0004","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1016\/j.jinf.2020.03.005","article-title":"Clinical features of COVID-19 in elderly patients:a comparison with young and middle-aged patients","volume":"80","author":"Liu","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.apmt.2020.100887_bib0005","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","volume":"46","author":"Ruan","year":"2020","journal-title":"Intens Care Med"},{"key":"10.1016\/j.apmt.2020.100887_bib0006","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet North Am Ed"},{"key":"10.1016\/j.apmt.2020.100887_bib0007","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1086\/323130","article-title":"A macroproblem that starts with microadherence","volume":"33","author":"Darouiche","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.apmt.2020.100887_bib0008","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3389\/fmicb.2017.01041","article-title":"Secondary bacterial infections associated with influenza pandemics","volume":"8","author":"Morris","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.apmt.2020.100887_bib0009","doi-asserted-by":"crossref","first-page":"556","DOI":"10.3390\/antiox8110556","article-title":"Nitric oxide-releasing polymeric materials for antimicrobial applications: a review","volume":"8","author":"Rong","year":"2019","journal-title":"Antioxidants"},{"key":"10.1016\/j.apmt.2020.100887_bib0010","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1126\/science.1361684","article-title":"NO news is good news","volume":"258","author":"Culotta","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.apmt.2020.100887_bib0011","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/scientificamerican0592-68","article-title":"Biological roles of nitric oxide","volume":"266","author":"Snyder","year":"1992","journal-title":"Sci Am"},{"key":"10.1016\/j.apmt.2020.100887_bib0012","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1021\/acsabm.9b00237","article-title":"Catalyzed nitric oxide release via cu nanoparticles leads to an increase in antimicrobial effects and hemocompatibility for short-term extracorporeal circulation","volume":"2","author":"Douglass","year":"2019","journal-title":"ACS Appl Bio Mater"},{"key":"10.1016\/j.apmt.2020.100887_bib0013","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1021\/acsbiomaterials.8b01320","article-title":"Liquid-Infused nitric-oxide-releasing silicone foley urinary catheters for prevention of catheter-associated urinary tract infections","volume":"5","author":"Homeyer","year":"2019","journal-title":"ACS Biomater Sci Eng"},{"key":"10.1016\/j.apmt.2020.100887_bib0014","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1002\/jbm.b.34065","article-title":"Nitric oxide releasing vascular catheters for eradicating bacterial infection","volume":"106","author":"Pant","year":"2018","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"10.1016\/j.apmt.2020.100887_bib0015","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1086\/425357","article-title":"Inhalation of nitric oxide in the treatment of severe acute respiratory syndrome: a rescue trial in Beijing","volume":"39","author":"Chen","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.apmt.2020.100887_bib0016","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1182\/blood-2006-10-053827","article-title":"A new mechanism for nitric oxide - and cGMP-mediated platelet inhibition","volume":"109","author":"Du","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.apmt.2020.100887_bib0017","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1089\/ars.2007.1959","article-title":"Nitric oxide in the vasculature: where does it come from and where does it go? A quantitative perspective","volume":"10","author":"Chen","year":"2008","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.apmt.2020.100887_bib0018","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1749-6632.1997.tb51989.x","article-title":"Nitric oxide in the vasculature: physiology and pathophysiology","volume":"811","author":"Moncada","year":"1997","journal-title":"Ann N Y Acad Sci"},{"issue":"Suppl 2","key":"10.1016\/j.apmt.2020.100887_bib0019","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1186\/ar2465","article-title":"Role of nitric oxide in the gastrointestinal tract","volume":"10","author":"Lanas","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.apmt.2020.100887_bib0020","first-page":"159","article-title":"Why is nitric oxide important for our brain?","volume":"30","author":"Dzoljic","year":"2015","journal-title":"Funct Neurol"},{"key":"10.1016\/j.apmt.2020.100887_bib0021","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1189\/jlb.1010550","article-title":"Nitric oxide and redox mechanisms in the immune response","volume":"89","author":"Wink","year":"2011","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.apmt.2020.100887_bib0022","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0968-0004(97)01147-X","article-title":"Biosynthesis and action of nitric oxide in mammalian cells","volume":"22","author":"Mayer","year":"1997","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.apmt.2020.100887_bib0023","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.freeradbiomed.2010.04.004","article-title":"Subcellular and cellular locations of nitric oxide synthase isoforms as determinants of health and disease","volume":"49","author":"Villanueva","year":"2010","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.apmt.2020.100887_bib0024","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/364577a0","article-title":"Janus faces of nitric oxide","volume":"364","author":"Snyder","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.apmt.2020.100887_bib0025","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1039\/c2cs15271a","article-title":"Nitric oxide release: part III. Measurement and reporting","volume":"41","author":"Coneski","year":"2012","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.apmt.2020.100887_bib0026","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/hep.510300310","article-title":"Nitric oxide production and inducible nitric oxide synthase expression in peritoneal macrophages of cirrhotic patients","volume":"30","author":"Jimenez","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.apmt.2020.100887_bib0027","doi-asserted-by":"crossref","first-page":"C254","DOI":"10.1152\/ajpcell.00315.2016","article-title":"Nitric oxide: what's new to NO?","volume":"312","author":"Ghimire","year":"2017","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.apmt.2020.100887_bib0028","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.freeradbiomed.2014.05.016","article-title":"Regulation of obesity and insulin resistance by nitric oxide","volume":"73","author":"Sansbury","year":"2014","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.apmt.2020.100887_bib0029","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1046\/j.1365-201X.2001.00891.x","article-title":"Role of nitric oxide in inflammation","volume":"173","author":"Laroux","year":"2001","journal-title":"Acta Physiol Scand"},{"key":"10.1016\/j.apmt.2020.100887_bib0030","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejmech.2015.04.040","article-title":"The role of antioxidants in the chemistry of oxidative stress: a review","volume":"97","author":"Pisoschi","year":"2015","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apmt.2020.100887_bib0031","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0005-2728(99)00019-5","article-title":"Relationships between nitric oxide, nitroxyl ion, nitrosonium cation and peroxynitrite","volume":"1411","author":"Hughes","year":"1999","journal-title":"Biochim et Biophys Acta (BBA) - Bioenerg"},{"key":"10.1016\/j.apmt.2020.100887_bib0032","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.cbpa.2012.10.016","article-title":"Mechanisms of S-nitrosothiol formation and selectivity in nitric oxide signaling","volume":"16","author":"Smith","year":"2012","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.apmt.2020.100887_bib0033","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1073\/pnas.98.1.355","article-title":"The biological lifetime of nitric oxide: implications for the perivascular dynamics of NO and O2","volume":"98","author":"Thomas","year":"2001","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.apmt.2020.100887_bib0034","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1021\/cr0000271","article-title":"Mechanistic aspects of the reactions of nitric oxide with transition-metal complexes","volume":"102","author":"Ford","year":"2002","journal-title":"Chem Rev"},{"key":"10.1016\/j.apmt.2020.100887_bib0035","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.redox.2012.11.002","article-title":"Oxygen dependence of nitric oxide-mediated signaling","volume":"1","author":"Hickok","year":"2013","journal-title":"Redox Biol"},{"key":"10.1016\/j.apmt.2020.100887_bib0036","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.redox.2015.05.002","article-title":"Breathing new life into nitric oxide signaling: a brief overview of the interplay between oxygen and nitric oxide","volume":"5","author":"Thomas","year":"2015","journal-title":"Redox Biol"},{"key":"10.1016\/j.apmt.2020.100887_bib0037","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0005-2728(99)00020-1","article-title":"Nitric oxide metabolism and breakdown","volume":"1411","author":"Kelm","year":"1999","journal-title":"Biochim et Biophys Acta (BBA) - Bioenerg"},{"key":"10.1016\/j.apmt.2020.100887_bib0038","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1007\/s00705-016-2904-x","article-title":"Activation of toll-like receptor signaling pathways leading to nitric oxide-mediated antiviral responses","volume":"161","author":"Abdul-Cader","year":"2016","journal-title":"Arch Virol"},{"key":"10.1016\/j.apmt.2020.100887_bib0039","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.freeradbiomed.2006.01.037","article-title":"Role of epithelial nitric oxide in airway viral infection","volume":"41","author":"Xu","year":"2006","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.apmt.2020.100887_bib0040","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1046\/j.1365-2567.2000.00142.x","article-title":"Nitric oxide and virus infection","volume":"101","author":"Akaike","year":"2000","journal-title":"Immunology"},{"key":"10.1016\/j.apmt.2020.100887_bib0041","first-page":"25","article-title":"S-nitrosylation of viral proteins: molecular bases for antiviral effect of nitric oxide","volume":"48","author":"Colasanti","year":"1999","journal-title":"IUBMB Life"},{"key":"10.1016\/j.apmt.2020.100887_bib0042","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1074-7613(00)80003-5","article-title":"An antiviral mechanism of nitric oxide: inhibition of a viral protease","volume":"10","author":"Saura","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.apmt.2020.100887_bib0043","doi-asserted-by":"crossref","first-page":"e31688","DOI":"10.1371\/journal.pone.0031688","article-title":"The nitric oxide pathway provides innate antiviral protection in conjunction with the type I interferon pathway in fibroblasts","volume":"7","author":"Mehta","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.apmt.2020.100887_bib0044","doi-asserted-by":"crossref","first-page":"4878","DOI":"10.1158\/0008-5472.CAN-08-4695","article-title":"Nitric oxide induces early viral transcription coincident with increased DNA damage and mutation rates in human papillomavirus-infected cells","volume":"69","author":"Wei","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.apmt.2020.100887_bib0045","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1002\/eji.200535587","article-title":"Nitric oxide and peroxynitrite have different antiviral effects against hantavirus replication and free mature virions","volume":"36","author":"Klingstrom","year":"2006","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.apmt.2020.100887_bib0046","doi-asserted-by":"crossref","unstructured":"E. Ryan, R. Hollingworth, R. Grand, Activation of the DNA damage response by RNA viruses, 6 (2016) 2, https:\/\/dx.doi.org\/ 10.3390\/biom6010002.","DOI":"10.3390\/biom6010002"},{"key":"10.1016\/j.apmt.2020.100887_bib0047","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s00011-015-0857-2","article-title":"Role of nitric oxide in immune responses against viruses: beyond microbicidal activity","volume":"64","author":"Uehara","year":"2015","journal-title":"Inflamm Res"},{"key":"10.1016\/j.apmt.2020.100887_bib0048","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jaci.2009.04.041","article-title":"Nitric oxide inhibits IFN regulatory factor 1 and nuclear factor-kappaB pathways in rhinovirus-infected epithelial cells","volume":"124","author":"Koetzler","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.apmt.2020.100887_bib0049","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jaci.2008.09.041","article-title":"Nitric oxide inhibits human rhinovirus-induced transcriptional activation of CXCL10 in airway epithelial cells","volume":"123","author":"Koetzler","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.apmt.2020.100887_bib0050","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1007\/s00705-014-2201-5","article-title":"Downregulation of inducible nitric oxide synthase (iNOS) expression is implicated in the antiviral activity of acetylsalicylic acid in HCV-expressing cells","volume":"159","author":"Rios-Ibarra","year":"2014","journal-title":"Arch Virol"},{"key":"10.1016\/j.apmt.2020.100887_bib0051","first-page":"611","article-title":"Broad-spectrum antiviral effect of chebulagic acid and punicalagin on respiratory syncytial virus infection in a BALB\/c model","volume":"9","author":"Xie","year":"2016","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.apmt.2020.100887_bib0052","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1124\/mol.106.031427","article-title":"Activation of the adenosine A1 receptor inhibits HIV-1 tat-induced apoptosis by reducing nuclear factor-kappaB activation and inducible nitric-oxide synthase","volume":"72","author":"Pingle","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.apmt.2020.100887_bib0053","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1136\/thx.52.2.185","article-title":"Decreased exhaled nitric oxide in subjects with HIV infection","volume":"52","author":"Loveless","year":"1997","journal-title":"Thorax"},{"key":"10.1016\/j.apmt.2020.100887_bib0054","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/jmv.20953","article-title":"The membrane protein of SARS-CoV suppresses NF-kappaB activation","volume":"79","author":"Fang","year":"2007","journal-title":"J Med Virol"},{"key":"10.1016\/j.apmt.2020.100887_bib0055","doi-asserted-by":"crossref","unstructured":"L. A. Perrone, J. A. Belser, D. A. Wadford, J. M. Katz, T. M. Tumpey, Inducible nitric oxide contributes to viral pathogenesis following highly pathogenic influenza virus infection in mice, 207 (2013) 1576, https:\/\/dx.doi.org\/ 10.1093\/infdis\/jit062.","DOI":"10.1093\/infdis\/jit062"},{"key":"10.1016\/j.apmt.2020.100887_bib0056","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1073\/pnas.93.6.2448","article-title":"Pathogenesis of influenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals","volume":"93","author":"Akaike","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apmt.2020.100887_bib0057","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S1473-3099(02)00262-1","article-title":"Role of nitric oxide in HIV-1 infection: friend or foe?","volume":"2","author":"Torre","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.apmt.2020.100887_bib0058","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/1743-422X-10-267","article-title":"Nitric oxide synthase expression correlates with death in an experimental mouse model of dengue with CNS involvement","volume":"10","author":"De Souza","year":"2013","journal-title":"Virol J"},{"key":"10.1016\/j.apmt.2020.100887_bib0059","doi-asserted-by":"crossref","first-page":"4547","DOI":"10.1128\/JVI.72.6.4547-4551.1998","article-title":"Does nitric oxide play a critical role in viral infections?","volume":"72","author":"Reiss","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.apmt.2020.100887_bib0060","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/0923-2494(96)84920-0","article-title":"The antiviral role of nitric oxide","volume":"146","author":"Mannick","year":"1995","journal-title":"Res Immunol"},{"key":"10.1016\/j.apmt.2020.100887_bib0061","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1128\/JVI.72.2.934-942.1998","article-title":"Nitric oxide inhibits rhinovirus-induced cytokine production and viral replication in a human respiratory epithelial cell line","volume":"72","author":"Sanders","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.apmt.2020.100887_bib0062","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jaci.2004.01.755","article-title":"Role of nasal nitric oxide in the resolution of experimental rhinovirus infection","volume":"113","author":"Sanders","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.apmt.2020.100887_bib0063","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.vetimm.2010.03.022","article-title":"Nitric oxide is elicited and inhibits viral replication in pigs infected with porcine respiratory coronavirus but not porcine reproductive and respiratory syndrome virus","volume":"136","author":"Jung","year":"2010","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.apmt.2020.100887_bib0064","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1172\/JCI116479","article-title":"Evidence for antiviral effect of nitric oxide. inhibition of herpes simplex virus type 1 replication","volume":"91","author":"Croen","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.apmt.2020.100887_bib0065","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.niox.2013.03.007","article-title":"Gaseous nitric oxide reduces influenza infectivity in vitro","volume":"31","author":"Regev-Shoshani","year":"2013","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.apmt.2020.100887_bib0066","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.4187\/respcare.05501451","article-title":"The antimicrobial effect of nitric oxide on the bacteria that cause nosocomial pneumonia in mechanically ventilated patients in the intensive care unit","volume":"50","author":"McMullin","year":"2005","journal-title":"Respir Care"},{"key":"10.1016\/j.apmt.2020.100887_bib0067","first-page":"123","article-title":"Asthma, viruses, and nitric oxide","volume":"220","author":"Sanders","year":"1999","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.apmt.2020.100887_bib0068","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12917-017-0976-9","article-title":"Nitric oxide-generating compound GSNO suppresses porcine circovirus type 2 infection in vitro and in vivo","volume":"13","author":"Liu","year":"2017","journal-title":"BMC Vet Res"},{"key":"10.1016\/j.apmt.2020.100887_bib0069","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijid.2004.04.012","article-title":"Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound","volume":"8","author":"Keyaerts","year":"2004","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.apmt.2020.100887_bib0070","doi-asserted-by":"crossref","first-page":"8880","DOI":"10.1128\/JVI.73.10.8880-8883.1999","article-title":"Inhibition of influenza virus replication by nitric oxide","volume":"73","author":"Rimmelzwaan","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.apmt.2020.100887_bib0071","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.virusres.2006.03.005","article-title":"Exogenous nitric oxide inhibits Crimean Congo hemorrhagic fever virus","volume":"120","author":"Simon","year":"2006","journal-title":"Virus Res"},{"key":"10.1016\/j.apmt.2020.100887_bib0072","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2019.104559","article-title":"NVN1000, a novel nitric oxide-releasing compound, inhibits HPV-18 virus production by interfering with E6 and E7 oncoprotein functions","volume":"170","author":"Banerjee","year":"2019","journal-title":"Antivir Res"},{"key":"10.1016\/j.apmt.2020.100887_bib0073","first-page":"1100","article-title":"A phase 2 controlled study of SB206, a topical nitric oxide-releasing drug for extragenital wart treatment","volume":"17","author":"Tyring","year":"2018","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.apmt.2020.100887_bib0074","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1021\/jm020299r","article-title":"Synthesis of 3\u2032- and 5\u2032-nitrooxy pyrimidine nucleoside nitrate esters: \"nitric oxide donor\" agents for evaluation as anticancer and antiviral agents","volume":"46","author":"Naimi","year":"2003","journal-title":"J Med Chem"},{"key":"10.1016\/j.apmt.2020.100887_bib0075","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1586\/era.11.10","article-title":"Hydroxycarbamide: a user's guide for chronic myeloproliferative disorders","volume":"11","author":"Spivak","year":"2011","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.apmt.2020.100887_bib0076","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.3851\/IMP1668","article-title":"Hydroxyurea suppresses HCV replication in humans: a Phase I trial of oral hydroxyurea in chronic hepatitis C patients","volume":"15","author":"Nozaki","year":"2010","journal-title":"Antivir Ther"},{"key":"10.1016\/j.apmt.2020.100887_bib0077","first-page":"215","article-title":"Amazing results with hydroxyurea therapy in chronic hepatitis B: a preliminary report","volume":"10","author":"Kashani","year":"2010","journal-title":"Hepat Mon"},{"key":"10.1016\/j.apmt.2020.100887_bib0078","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bcp.2017.03.022","article-title":"Hydroxyurea inhibits parvovirus B19 replication in erythroid progenitor cells","volume":"136","author":"Bonvicini","year":"2017","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.apmt.2020.100887_bib0079","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1126\/science.7973634","article-title":"Hydroxyurea as an inhibitor of human immunodeficiency virus-type 1 replication","volume":"266","author":"Lori","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.apmt.2020.100887_bib0080","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1016\/S0040-4039(01)00614-1","article-title":"Glycosylated diazeniumdiolates: a novel class of enzyme-activated nitric oxide donors","volume":"42","author":"Wu","year":"2001","journal-title":"Tetrahedron Lett"},{"key":"10.1016\/j.apmt.2020.100887_bib0081","doi-asserted-by":"crossref","first-page":"6710","DOI":"10.1039\/c1cc12130h","article-title":"Novel protection\u2013deprotection strategies in diazeniumdiolate chemistry: synthesis of V-IPA\/NO","volume":"47","author":"Nandurdikar","year":"2011","journal-title":"Chem Commun"},{"key":"10.1016\/j.apmt.2020.100887_bib0082","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2174\/1568026054679281","article-title":"An introduction to NO-related therapeutic agents","volume":"5","author":"Thatcher","year":"2005","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.apmt.2020.100887_bib0083","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2174\/156720506777632925","article-title":"NO chimeras as therapeutic agents in Alzheimer's disease","volume":"3","author":"Thatcher","year":"2006","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.apmt.2020.100887_bib0084","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s00280-011-1654-4","article-title":"Nitric oxide: role in tumour biology and iNOS\/NO-based anticancer therapies","volume":"67","author":"Singh","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.apmt.2020.100887_bib0085","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1021\/jm960379t","article-title":"Water Soluble Furoxan Derivatives as NO Prodrugs","volume":"40","author":"Sorba","year":"1997","journal-title":"J Med Chem"},{"key":"10.1016\/j.apmt.2020.100887_bib0086","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nrd2466","article-title":"The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics","volume":"7","author":"Lundberg","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.apmt.2020.100887_bib0087","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3389\/fphar.2012.00036","article-title":"Bilirubin: an Endogenous Molecule with Antiviral Activity in vitro","volume":"3","author":"Santangelo","year":"2012","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.apmt.2020.100887_bib0088","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2174\/138955711796355285","article-title":"Synthesis and biological activity of chiral dihydropyrazole: potential lead for drug design","volume":"11","author":"Liu","year":"2011","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.apmt.2020.100887_bib0089","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1021\/bm401048s","article-title":"Narrow therapeutic window of ribavirin as an inhibitor of nitric oxide synthesis is broadened by macromolecular prodrugs","volume":"14","author":"Wohl","year":"2013","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.apmt.2020.100887_bib0090","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1517\/13543784.8.8.1209","article-title":"Nitric oxide scavengers as a therapeutic approach to nitric oxide mediated disease","volume":"8","author":"Fricker","year":"1999","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.apmt.2020.100887_bib0091","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1378\/chest.107.4.1107","article-title":"Efficacy of inhaled nitric oxide in patients with severe ARDS","volume":"107","author":"Rossaint","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.apmt.2020.100887_bib0092","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1542\/peds.98.4.698","article-title":"Acute response to inhaled nitric oxide in newborns with respiratory failure and pulmonary hypertension","volume":"98","author":"Day","year":"1996","journal-title":"Pediatrics"},{"key":"10.1016\/j.apmt.2020.100887_bib0093","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/00000542-199303000-00005","article-title":"Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation","volume":"78","author":"Frostell","year":"1993","journal-title":"Anesthesiology"},{"key":"10.1016\/j.apmt.2020.100887_bib0094","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1183\/09031936.93.06020177","article-title":"Inhalation of nitric oxide modulates methacholine-induced bronchoconstriction in the rabbit","volume":"6","author":"Hogman","year":"1993","journal-title":"Eur Respir J"},{"key":"10.1016\/j.apmt.2020.100887_bib0095","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s15010-016-0879-x","article-title":"Gaseous nitric oxide to treat antibiotic resistant bacterial and fungal lung infections in patients with cystic fibrosis: a phase I clinical study","volume":"44","author":"Deppisch","year":"2016","journal-title":"Infection"},{"key":"10.1016\/j.apmt.2020.100887_bib0096","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2020.03.004","article-title":"Antibiofilm and mucolytic action of nitric oxide delivered via gas or macromolecular donor using in vitro and ex vivo models","author":"Rouillard","year":"2020","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.apmt.2020.100887_bib0097","unstructured":"C. C. Miller, D. R. Hole, R. E. Lee, Use of high dose concentrations of gaseous nitric oxide, US 20080193566A1, (2008), https:\/\/patents.google.com\/patent\/US20080193566A1."},{"key":"10.1016\/j.apmt.2020.100887_bib0098","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.niox.2008.08.002","article-title":"Gaseous nitric oxide bactericidal activity retained during intermittent high-dose short duration exposure","volume":"20","author":"Miller","year":"2009","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.apmt.2020.100887_bib0099","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1161\/01.CIR.0000134595.80170.62","article-title":"Inhaled nitric oxide: a selective pulmonary vasodilator: current uses and therapeutic potential","volume":"109","author":"Ichinose","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.apmt.2020.100887_bib0100","unstructured":"FDACDER, approval package for: application number: NDA 20845\/S17. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2015\/020845Orig1s017.pdf, 2015 (Accessed 1 July 2020)."},{"key":"10.1016\/j.apmt.2020.100887_bib0101","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1128\/AAC.49.3.1209-1212.2005","article-title":"Inhaled nitric oxide treatment of patients with pulmonary tuberculosis evidenced by positive sputum smears","volume":"49","author":"Long","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apmt.2020.100887_bib0102","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/BF02256308","article-title":"Acute respiratory distress syndrome","volume":"10","author":"Chen","year":"2003","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.apmt.2020.100887_bib0103","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1046\/j.1440-1681.2001.03446.x","article-title":"The lung is the major site that produces nitric oxide to induce acute pulmonary oedema in endotoxin shock","volume":"28","author":"Lee","year":"2001","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.apmt.2020.100887_bib0104","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/BF02255998","article-title":"Nitric oxide mediates lung injury induced by ischemia-reperfusion in rats","volume":"10","author":"Kao","year":"2003","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.apmt.2020.100887_bib0105","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002787.pub3","article-title":"Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) in children and adults","author":"Gebistorf","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.apmt.2020.100887_bib0106","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/anae.13628","article-title":"The effect of inhaled nitric oxide in acute respiratory distress syndrome in children and adults: a cochrane systematic review with trial sequential analysis","volume":"72","author":"Karam","year":"2017","journal-title":"Anaesthesia"},{"key":"10.1016\/j.apmt.2020.100887_bib0107","doi-asserted-by":"crossref","first-page":"157","DOI":"10.7150\/ijms.3880","article-title":"Inhaled nitric oxide therapy fails to improve outcome in experimental severe influenza","volume":"9","author":"Darwish","year":"2012","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.apmt.2020.100887_bib0108","doi-asserted-by":"crossref","DOI":"10.1016\/j.micinf.2020.05.002","article-title":"Could nasal nitric oxide help to mitigate the severity of COVID-19?","author":"Martel","year":"2020","journal-title":"Microbes Infect"},{"key":"10.1016\/j.apmt.2020.100887_bib0109","article-title":"Protocol for a randomized controlled trial testing inhaled nitric oxide therapy in spontaneously breathing patients with COVID-19","author":"Berra","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.apmt.2020.100887_bib0110","article-title":"Protocol of a randomized controlled trial testing inhaled Nitric Oxide in mechanically ventilated patients with severe acute respiratory syndrome in COVID-19 (SARS-CoV-2)","author":"Lei","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.apmt.2020.100887_bib0111","article-title":"Nitric oxide gas inhalation to prevent COVID-2019 in healthcare providers","author":"Gianni","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.apmt.2020.100887_bib0112","unstructured":"J. Road, Inhaled Gaseous Nitric Oxide (gNO) Antimicrobial Treatment of Difficult Bacterial and Viral Lung (COVID-19) Infections (NCT03331445), (2020)"},{"key":"10.1016\/j.apmt.2020.100887_bib0113","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1088\/0967-3334\/17\/4\/004","article-title":"Half-life of nitric oxide in aqueous solutions with and without haemoglobin","volume":"17","author":"Hakim","year":"1996","journal-title":"Physiol Meas"},{"key":"10.1016\/j.apmt.2020.100887_bib0114","first-page":"H2163","article-title":"Estimation of nitric oxide production and reaction rates in tissue by use of a mathematical model","volume":"274","author":"Vaughn","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.apmt.2020.100887_bib0115","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1021\/acsbiomaterials.9b01384","article-title":"Mode of Nitric Oxide Delivery Affects Antibacterial Action","volume":"6","author":"Hall","year":"2019","journal-title":"ACS Biomater Sci Eng"},{"key":"10.1016\/j.apmt.2020.100887_bib0116","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1046\/j.1365-2133.1999.03204.x","article-title":"Molluscum contagiosum effectively treated with a topical acidified nitrite, nitric oxide liberating cream","volume":"141","author":"Ormerod","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.apmt.2020.100887_bib0117","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.jaad.2019.09.064","article-title":"Efficacy and tolerability of an investigational nitric oxide\u2013releasing topical gel in patients with molluscum contagiosum: a randomized clinical trial","volume":"82","author":"Hebert","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.apmt.2020.100887_bib0118","unstructured":"NOVAN, novan reports top-line efficacy results from phase 3 trials of SB206 for Molluscum Contagiosum. http:\/\/investors.novan.com\/news-releases\/news-release-details\/novan-reports-top-line-efficacy-results-phase-3-trials-sb206, 2020 (Accessed 1 July 2020)."},{"key":"10.1016\/j.apmt.2020.100887_bib0119","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101734","article-title":"Mitigation of the replication of SARS-CoV-2 by nitric oxide in vitro","volume":"37","author":"Akaberi","year":"2020","journal-title":"Redox Biol"},{"key":"10.1016\/j.apmt.2020.100887_bib0120","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1172\/JCI119702","article-title":"Nitric oxide inhibition of coxsackievirus replication in vitro","volume":"100","author":"Zaragoza","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.apmt.2020.100887_bib0121","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1128\/jvi.71.7.5227-5235.1997","article-title":"Inhibition of Japanese encephalitis virus infection by nitric oxide: antiviral effect of nitric oxide on RNA virus replication","volume":"71","author":"Lin","year":"1997","journal-title":"J Virol"},{"key":"10.1016\/j.apmt.2020.100887_bib0122","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1128\/JVI.79.3.1966-1969.2005","article-title":"Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus","volume":"79","author":"Akerstrom","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.apmt.2020.100887_bib0123","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1039\/C4TB01839G","article-title":"Reduction in thrombosis and bacterial adhesion with 7 Day implantation of S-Nitroso-N-acetylpenicillamine (SNAP)-Doped Elast-eon E2As Catheters in Sheep","volume":"3","author":"Brisbois","year":"2015","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.apmt.2020.100887_bib0124","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1039\/c2cs15272j","article-title":"Nitric oxide release: part I. macromolecular scaffolds","volume":"41","author":"Riccio","year":"2012","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.apmt.2020.100887_bib0125","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1039\/c2cs15273h","article-title":"Nitric oxide release: part II. therapeutic applications","volume":"41","author":"Carpenter","year":"2012","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.apmt.2020.100887_bib0126","doi-asserted-by":"crossref","first-page":"27316","DOI":"10.1021\/acsami.8b08647","article-title":"Achieving Long-Term Biocompatible Silicone via Covalently Immobilized S-Nitroso- N-acetylpenicillamine (SNAP) that exhibits 4 months of sustained nitric oxide release","volume":"10","author":"Hopkins","year":"2018","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.apmt.2020.100887_bib0127","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jconrel.2015.12.056","article-title":"Biodegradable poly(lactic-co-glycolic acid) microspheres loaded with S-nitroso-N-acetyl-D-penicillamine for controlled nitric oxide delivery","volume":"225","author":"Lautner","year":"2016","journal-title":"J Control Release"},{"key":"10.1016\/j.apmt.2020.100887_bib0128","article-title":"Characterization of a Nitric Oxide (NO) donor molecule and Cerium Oxide Nanoparticle (CNP) interactions and their synergistic antimicrobial potential for biomedical applications","author":"Estes","year":"2020","journal-title":"J Colloid Interface Sci"},{"key":"10.1016\/j.apmt.2020.100887_bib0129","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1021\/acsnano.9b05976","article-title":"Nanoparticles encapsulating nitrosylated maytansine to enhance radiation therapy","volume":"14","author":"Gao","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.apmt.2020.100887_bib0130","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1002\/jbm.a.36657","article-title":"Zinc\u2010oxide nanoparticles act catalytically and synergistically with nitric oxide donors to enhance antimicrobial efficacy","volume":"107","author":"Singha","year":"2019","journal-title":"J Biomed Mater Res Part A"},{"key":"10.1016\/j.apmt.2020.100887_bib0131","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jconrel.2015.02.007","article-title":"Delivering nitric oxide with nanoparticles","volume":"205","author":"Quinn","year":"2015","journal-title":"J Control Release"},{"key":"10.1016\/j.apmt.2020.100887_bib0132","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1039\/C6BM00271D","article-title":"Recent advances in thromboresistant and antimicrobial polymers for biomedical applications: just say yes to nitric oxide (NO)","volume":"4","author":"Wo","year":"2016","journal-title":"Biomater Sci"},{"key":"10.1016\/j.apmt.2020.100887_bib0133","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.actbio.2016.11.070","article-title":"A review of the recent advances in antimicrobial coatings for urinary catheters","volume":"50","author":"Singha","year":"2017","journal-title":"Acta Biomater"},{"key":"10.1016\/j.apmt.2020.100887_bib0134","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.freeradbiomed.2007.04.026","article-title":"Methods to detect nitric oxide and its metabolites in biological samples","volume":"43","author":"Bryan","year":"2007","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.apmt.2020.100887_bib0135","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1378\/chest.113.6.1650","article-title":"Delivery of inhaled nitric oxide using the Ohmeda INOvent Delivery System","volume":"113","author":"Kirmse","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.apmt.2020.100887_bib0136","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/(SICI)1099-0496(199907)28:1<3::AID-PPUL2>3.0.CO;2-S","article-title":"Inhaled nitric oxide, oxygen, and alkalosis: dose-response interactions in a lamb model of pulmonary hypertension","volume":"28","author":"Heidersbach","year":"1999","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.apmt.2020.100887_bib0137","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00430-003-0198-6","article-title":"Nitric oxide donors inhibit the coxsackievirus B3 proteinases 2A and 3C in vitro, virus production in cells, and signs of myocarditis in virus-infected mice","volume":"193","author":"Zell","year":"2004","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.apmt.2020.100887_bib0138","doi-asserted-by":"crossref","first-page":"17873","DOI":"10.1074\/jbc.M801182200","article-title":"Bioactivation of nitroglycerin by purified mitochondrial and cytosolic aldehyde dehydrogenases","volume":"283","author":"Beretta","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apmt.2020.100887_bib0139","doi-asserted-by":"crossref","first-page":"12159","DOI":"10.1073\/pnas.0503723102","article-title":"An essential role for mitochondrial aldehyde dehydrogenase in nitroglycerin bioactivation","volume":"102","author":"Chen","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apmt.2020.100887_bib0140","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.niox.2019.01.001","article-title":"Pharmacokinetics and pharmacodynamics of nitric oxide mimetic agents","volume":"84","author":"Horton","year":"2019","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.apmt.2020.100887_bib0141","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1016\/j.bbagen.2013.02.004","article-title":"S-nitrosoglutathione","volume":"1830","author":"Broniowska","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.apmt.2020.100887_bib0142","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3389\/fmicb.2015.00517","article-title":"Broad-spectrum antiviral agents","volume":"6","author":"Zhu","year":"2015","journal-title":"Front Microbiol"},{"key":"10.1016\/j.apmt.2020.100887_bib0143","doi-asserted-by":"crossref","first-page":"a48","DOI":"10.2741\/986","article-title":"Replication of respiratory syncytial virus is inhibited in target cells generating nitric oxide in situ","volume":"8","author":"Ali-Ahmad","year":"2003","journal-title":"Front Biosci"},{"issue":"Suppl 1","key":"10.1016\/j.apmt.2020.100887_bib0144","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1038\/sj.cdd.4401115","article-title":"Does nitric oxide play a pathogenic role in hepatitis C virus infection?","volume":"10","author":"Majano","year":"2003","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.apmt.2020.100887_bib0145","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.cclet.2008.12.009","article-title":"Synthesis and antiviral activity of 4H-[1,2,5]oxadiazolo[3,4-d]pyrimidine-5,7-dione 1-oxide nucleosides","volume":"20","author":"Shi","year":"2009","journal-title":"Chin Chem Lett"},{"key":"10.1016\/j.apmt.2020.100887_bib0146","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.bmcl.2014.11.065","article-title":"Synthesis and quantitative structure-activity relationship (QSAR) analysis of some novel oxadiazolo[3,4-d]pyrimidine nucleosides derivatives as antiviral agents","volume":"25","author":"Xu","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.apmt.2020.100887_bib0147","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.antiviral.2006.04.017","article-title":"L-nucleoside enantiomers as antivirals drugs: a mini-review","volume":"71","author":"Mathe","year":"2006","journal-title":"Antivir Res"},{"key":"10.1016\/j.apmt.2020.100887_bib0148","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.cclet.2011.01.010","article-title":"Synthesis of new pyrimidine nucleoside derivatives with nitric oxide donors for antiviral activity","volume":"22","author":"Shi","year":"2011","journal-title":"Chin Chem Lett"},{"key":"10.1016\/j.apmt.2020.100887_bib0149","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1128\/jvi.69.4.2208-2213.1995","article-title":"Inhibition of vesicular stomatitis virus infection by nitric oxide","volume":"69","author":"Bi","year":"1995","journal-title":"J Virol"},{"key":"10.1016\/j.apmt.2020.100887_bib0150","doi-asserted-by":"crossref","first-page":"530","DOI":"10.3389\/fchem.2019.00530","article-title":"Nitric Oxide (NO)-releasing macromolecules: rational design and biomedical applications","volume":"7","author":"Cheng","year":"2019","journal-title":"Front Chem"},{"key":"10.1016\/j.apmt.2020.100887_bib0151","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejphar.2014.05.012","article-title":"The design of nitric oxide donor drugs: s-nitrosothiol tDodSNO is a superior photoactivated donor in comparison to GSNO and SNAP","volume":"737","author":"Kumari","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.apmt.2020.100887_bib0152","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1021\/ja210771m","article-title":"Metal organic frameworks as nitric oxide catalysts","volume":"134","author":"Harding","year":"2012","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.apmt.2020.100887_bib0153","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1021\/acsinfecdis.9b00016","article-title":"Antibiofilm efficacy of nitric oxide-releasing alginates against cystic fibrosis bacterial pathogens","volume":"5","author":"Ahonen","year":"2019","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.apmt.2020.100887_bib0154","doi-asserted-by":"crossref","first-page":"367","DOI":"10.4103\/0250-474X.164770","article-title":"Smart polymers in nasal drug delivery","volume":"77","author":"Chonkar","year":"2015","journal-title":"Indian J Pharm Sci"},{"key":"10.1016\/j.apmt.2020.100887_bib0155","doi-asserted-by":"crossref","first-page":"215","DOI":"10.4103\/2231-4040.90876","article-title":"A review on mucoadhesive polymer used in nasal drug delivery system","volume":"2","author":"Chaturvedi","year":"2011","journal-title":"J Adv Pharm Technol Res"},{"key":"10.1016\/j.apmt.2020.100887_bib0156","doi-asserted-by":"crossref","first-page":"306","DOI":"10.4168\/aair.2019.11.3.306","article-title":"Influence of intranasal drugs on human nasal mucociliary clearance and ciliary beat frequency","volume":"11","author":"Jiao","year":"2019","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.apmt.2020.100887_bib0157","article-title":"Progress and promise of nitric oxide-releasing platforms","volume":"5","author":"Yang","year":"2018","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.apmt.2020.100887_bib0158","unstructured":"M. H. Schoenfisch, E. M. Hetrick, N. A. Stasko, C. B. Johnson, Use of nitric oxide to enhance the efficacy of silver and other topical wound care agents, US 8,399,005 B2, (2013), https:\/\/patents.google.com\/patent\/US8399005B2\/en."},{"key":"10.1016\/j.apmt.2020.100887_bib0159","unstructured":"M. H. Schoenfisch, J. H. Shin, N. Stasko, Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications, US 9.403,852 B2, (2016), https:\/\/patents.google.com\/patent\/US9403852B2\/en."},{"key":"10.1016\/j.apmt.2020.100887_bib0160","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1039\/B912493B","article-title":"Nitric oxide-releasing vehicles for biomedical applications","volume":"20","author":"Seabra","year":"2010","journal-title":"J. Mater. Chem."},{"key":"10.1016\/j.apmt.2020.100887_bib0161","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4103\/0971-9784.197820","article-title":"Extracorporeal membrane oxygenation in severe influenza infection with respiratory failure: a systematic review and meta-analysis","volume":"20","author":"Sukhal","year":"2017","journal-title":"Ann Card Anaesth"},{"key":"10.1016\/j.apmt.2020.100887_bib0162","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102434","article-title":"The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China","volume":"109","author":"Yang","year":"2020","journal-title":"J Autoimmun"},{"key":"10.1016\/j.apmt.2020.100887_bib0163","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3389\/fphar.2019.00298","article-title":"Drug prevention and control of ventilator-associated Pneumonia","volume":"10","author":"Xie","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.apmt.2020.100887_bib0164","doi-asserted-by":"crossref","DOI":"10.1002\/bit.27341","article-title":"S-Nitroso-N-acetylpenicillamine impregnated endotracheal tubes for prevention of ventilator-associated pneumonia","author":"Homeyer","year":"2020","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.apmt.2020.100887_bib0165","first-page":"1","article-title":"Toward an artificial endothelium: development of blood-compatible surfaces for extracorporeal life support","author":"Roberts","year":"2020","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1016\/j.apmt.2020.100887_bib0166","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/MAT.0000000000001173","article-title":"Initial ELSO guidance document: ECMO for COVID-19 patients with severe cardiopulmonary failure","volume":"66","author":"Bartlett","year":"2020","journal-title":"ASAIO J"},{"key":"10.1016\/j.apmt.2020.100887_bib0167","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s13054-020-02925-3","article-title":"COVID-19 and ECMO: the interplay between coagulation and inflammation-a narrative review","volume":"24","author":"Kowalewski","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.apmt.2020.100887_bib0168","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0140-6736(20)30920-X","article-title":"SARS-CoV-2 and viral sepsis: observations and hypotheses","volume":"395","author":"Li","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.apmt.2020.100887_bib0169","doi-asserted-by":"crossref","DOI":"10.1016\/j.bja.2020.04.079","article-title":"Extracorporeal membrane oxygenation for COVID-19-associated severe acute respiratory distress syndrome and risk of thrombosis","author":"Beyls","year":"2020","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.apmt.2020.100887_bib0170","doi-asserted-by":"crossref","first-page":"14614","DOI":"10.1128\/JVI.79.23.14614-14621.2005","article-title":"ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia","volume":"79","author":"Jia","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.apmt.2020.100887_bib0171","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41368-020-0074-x","article-title":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa","volume":"12","author":"Xu","year":"2020","journal-title":"Int J Oral Sci"},{"key":"10.1016\/j.apmt.2020.100887_bib0172","doi-asserted-by":"crossref","first-page":"e23710","DOI":"10.1371\/journal.pone.0023710","article-title":"Inhibition of SARS pseudovirus cell entry by lactoferrin binding to heparan sulfate proteoglycans","volume":"6","author":"Lang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.apmt.2020.100887_bib0173","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3389\/fmed.2018.00321","article-title":"Novel Surfaces in Extracorporeal Membrane Oxygenation Circuits","volume":"5","author":"Ontaneda","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.apmt.2020.100887_bib0174","doi-asserted-by":"crossref","first-page":"13105","DOI":"10.1021\/acs.langmuir.7b02970","article-title":"Covalent grafting of antifouling phosphorylcholine-based copolymers with antimicrobial nitric oxide releasing polymers to enhance infection-resistant properties of medical device coatings","volume":"33","author":"Liu","year":"2017","journal-title":"Langmuir"},{"key":"10.1016\/j.apmt.2020.100887_bib0175","doi-asserted-by":"crossref","first-page":"9070","DOI":"10.1021\/acsami.9b22442","article-title":"Multipronged approach to combat catheter-associated infections and thrombosis by combining nitric oxide and a Polyzwitterion: a 7 day in vivo study in a Rabbit Model","volume":"12","author":"Singha","year":"2020","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.apmt.2020.100887_bib0176","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.1016\/j.biomaterials.2011.03.036","article-title":"The hemocompatibility of a nitric oxide generating polymer that catalyzes S-nitrosothiol decomposition in an extracorporeal circulation model","volume":"32","author":"Major","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.apmt.2020.100887_bib0177","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1080\/00914037.2016.1163570","article-title":"Characterization of an S-nitroso-N-acetylpenicillamine-based nitric oxide releasing polymer from a translational perspective","volume":"65","author":"Goudie","year":"2016","journal-title":"Int J Polym Mater"}],"container-title":["Applied Materials Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352940720303358?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352940720303358?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T21:24:04Z","timestamp":1778880244000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352940720303358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":177,"alternative-id":["S2352940720303358"],"URL":"https:\/\/doi.org\/10.1016\/j.apmt.2020.100887","relation":{},"ISSN":["2352-9407"],"issn-type":[{"value":"2352-9407","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nitric oxide and viral infection: Recent developments in antiviral therapies and platforms","name":"articletitle","label":"Article Title"},{"value":"Applied Materials Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apmt.2020.100887","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100887"}}